Vasoactive intestinal peptide-induced prolactin release in hypothyroid patients

Dieguez C, Page M.D., Scanlon M.F. Growth hormone neuroregulation and its alterations in disease states. Clin Endocrinol. (Oxf.) 28: 109, 1988.

Ross F., Nusynowitz M.L. A syndrome of primary hypothyroidism, amenorrhea and galactorrhea. J. Clin. Endocrinol. Metab. 28: 591, 1968.

Edwards C.R., Forsythe I.A., Besser G.M. Amenorrhoea, galactorrhoea, and primary hypothyroidism with high circulating levels of prolactin. Br. Med. J. 3: 462, 1971.

Shimatsu A., Kato Y. Matsushita N., Katakami H., Yanaihara N., Imura H. Immunoreactive vasoactive intestinal polypeptide in rat hypophyseal portal blood. Endocrinology 108: 395, 1981.

Shimatsu A., Kato Y., Ohta H., Tojo K., Kabayama Y., Inoue T., Yanaihara N., Imura H. Involvement of hypothalamic vasoactive intestinal polypeptide (VIP) in prolactin secretion induced by serotonin in rats. Proc. Soc. Exp. Biol. Med. 175: 414, 1984.

Kato Y., Iwasaki Y., Iwasaki J., Abe H., Yanaihara N., Imura H. Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology 103: 554, 1978.

Ottesen B., Andersen A.N., Gerstenberg T., Ulrichsen H., Manthorpe T., Fahrekrug J. VIP stimulates prolactin release in women. Lancet 2:696, 1981.

Bataille D., Talbot J.N., Milhaud C, Mutt V., Rosselin G. Effect du peptide intestinal vasoactif (VIP) sur la secretion de prolactine chez I’homme. C.R. Hebd. Seances Acad. Sci. (Paris) 292: 511, 1981.

Conti A., Togni E., Travaglini P., Muratori M., Faglia G. Vasoactive intestinal polypeptide and dopamine: effect on prolactin secretion in normal women and in patients with microprolactinomas. Neuroendocrinology 46: 241, 1987.

Ruberg M., Rotsztejn W.H., Arancibia S., Besson J., Enjalbert A. Stimulation of prolactin release by vasoactive intestinal peptide (VIP). Eur. J. Pharmacol. 51: 319, 1978.

Segerson T.P., Lam K.S.L., Cacicedo L, Minamitani N., Fink J.S., Lechan R.M., Reichlin S. Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland. Endocrinology 125: 2221, 1989.

Lorenzo M.J., Sanchez-Franco F., de los Frailes M.T., Tolon R.M., Fernandez G., Cacicedo L. hyroid hormones regulate release and content of vasoactive intestinal peptide in cultured fetal cerebral cortical cells. Neuroendocrinology 55: 59, 1992.

Lam K.S.L., Lechan R.M., Minamitani N., Segerson T.P., Reichlin S. Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism. Endocrinology 124: 1077, 1989.

Toni R., Kakucska L, Mosca S., Marrama P., Lechan R.M. Hypothyroidism increases vasoactive intestinal polypeptide (VIP) immunoreactivity and gene expression in the rat hypothalamic paraventricular nucleus. Endocrinology 131: 976, 1992.

Chihara K., Iwasaki J., Minamitani N., Kaji H., Matsukura S., Tamaki N., Matsumoto S., Fujita T. Effect of vasoactive intestinal polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues. J. Clin. Endocrinol. Metab. 54: 773, 1982.

Valcavi R., Zini M., Portioli I. Thyroid hormones and growth hormone secretion. J. Endocrinol. Invest. 15: 313, 1992

Vale W., Blackwell R., Grant G. TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro. Endocrinology 93: 26, 1973.

Cataldo N.A., Cooper D.S., Chin W.W., Maloof F., Ridgway EC The effect of thyroid hormones on prolactin secretion by cultured bovine pituitary cells. Metabolism 31: 589, 1982.

Peters J.R., Foord S.M., Dieguez C, Scanlon M.F. TSH neuroregulation and alterations in disease states. Clin. Endocrinol. Metab. 12: 669, 1983.

Honbo K.S., van Herle A.J., Kellett K.A. Serum prolactin levels in untreated primary hypothyroidism. Am. J. Med. 64: 782, 1978.

Cooper D.S., Ridgway E.C., Kliman B., Kyellberg R.N., Maloof F. Metabolic clearance and production rates of prolactin in man. J. Clin. Invest. 64: 1669, 1979.

Pizzi M., Rubessa S., Simonazzi E., Zanagnolo V., Falsetti L, Memo M., Spano P.F. Requirement of oestrogens for the sensitivity of prolactin cells to vasoactive intestinal peptide in rats and man. J. Endocrinol. 132: 311, 1992.

Matsushita N., Kato Y., Katakami H., Shimatsu A., Yanaihara N., Imura H. Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro. J. Clin. Endocrinol. Metab. 53: 1297, 1981.

Chihara K., Kaji H., Minamitani N., Kodama H., Kita T., Goto B., Chiba T., Coy D.H., Fujita T. Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly. J. Clin. Endocrinol. Metab. 58: 81, 1984.

Enjalbert A., Epelbaum J., Arancibia S., Tapia-Arancibia L., Buet-Pajot T., Kordon C. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal polypeptide on prolactin and growth hormone secretion in vitro. Endocrinology 111: 42, 1982.

Edwards C.A., Dieguez C, Scanlon M.F. Effects of hypothyroidism, tri-iodothyronine and glucocorticoids on growth hormone responses to GHRH and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2. J. Endocrinol. 121: 31, 1989.